Rosas, I. O., Bräu, N., Waters, M., Go, R. C., Malhotra, A., Hunter, B. D., Bhagani, S., Skiest, D., Savic, S., Douglas, I. S., Garcia-Diaz, J., Aziz, M. S., Cooper, N., Youngstein, T., Sorbo, L. D., Zerda, D. J. D. L., Ustianowski, A., Gracian, A. C., Blyth, K. G., Carratalà, J., François, B., Benfield, T., Haslem, D., Bonfanti, P., van der Leest, C. H., Rohatgi, N., Wiese, L., Luyt, C. E., Bauer, R. N., Cai, F., Lee, I. T., Matharu, B., Metcalf, L., Wildum, S., Graham, E., Tsai, L., & Bao, M. (2022). tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA). EClinicalMedicine, 47, . http://access.bl.uk/ark:/81055/vdc_100155169364.0x000005